While safety concerns remain, the availability of probiotic bacteria which have been genetically engineered to secrete human IL-10 [68] offers a candidate alternative therapy for the prevention of NEC, particularly in cases where maternal milk is not available. This evidence concerns the gene IL10 and necrotizing enterocolitis.